Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment

N/ANot Yet RecruitingNCT06383325

Assiut University70 enrolled

Overview

Detection of hepatotoxcicity in acute leukemia and study the outcome of acute leukemia patients that suffer from hepatic toxiciyt

Chemotherapy induction associated with hepatotoxicity during the induction has never been studied the study aimed to determine whether chemotherapy induction is associated with livertoxicity or not

Study Type

OBSERVATIONAL

Enrollment

Conditions

Liver Toxicity, Chemically-Induced

Interventions

ChemotherapyCOMBINATION_PRODUCT

Detection of hepatotoxicity in acute leukemia patients during chemotherapy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients newly diagnosed with acute leukemia who are going to start chemotherapy treatment Exclusion Criteria: * patients previously diagnosed Acute leukemia and started treatment or in post treatment follow up

Outcomes

Primary Outcomes

Detection of hepatotoxcicity in acute leukemia during chemotherapy treatment

Evaluation of liver function test to identfy hepatotoxicity during chemotherapy treatment

Time frame: 3 months

Central Contacts

Nada mohamed hamada Hamada wahba

CONTACT

01140476425 Nm3390103@gmail.com

Enas Ahmed Reda alkareemy, Proffesor

CONTACT

01000004303 alkareemy@aun.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.